Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neurocrine Bioscienc
(NQ:
NBIX
)
145.63
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
260
Open
145.63
Bid (Size)
130.50 (3)
Ask (Size)
153.11 (1)
Prev. Close
145.63
Today's Range
145.63 - 145.63
52wk Range
100.52 - 157.98
Shares Outstanding
100,900,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
So Much For Expecting The Fed To Stick The Landing
August 04, 2024
Now is not the time to be fully invested.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
August 02, 2024
Apple and Meta had strong results, while AI spending remains robust.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Performance
YTD
+10.55%
+10.55%
1 Month
+2.38%
+2.38%
3 Month
+1.70%
+1.70%
6 Month
+1.87%
+1.87%
1 Year
+43.80%
+43.80%
More News
Read More
A Closer Look at 7 Analyst Recommendations For Neurocrine Biosciences
August 01, 2024
Via
Benzinga
NASDAQ:NBIX, a strong growth stock, setting up for a breakout.
July 26, 2024
Via
Chartmill
NASDAQ:NBIX, a growth stock which is not overvalued.
July 26, 2024
Via
Chartmill
Should Quality Investors Include NASDAQ:NBIX in Their Portfolio?
July 25, 2024
Via
Chartmill
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
July 10, 2024
Via
Benzinga
Why NASDAQ:NBIX Is a Promising High-Growth Stock in the Midst of Consolidation.
July 05, 2024
Via
Chartmill
NASDAQ:NBIX is not too expensive for the growth it is showing.
July 05, 2024
Via
Chartmill
Reasonable Growth, Debt Levels, and a High ROIC Make NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Appealing to Quality Investors.
July 04, 2024
Via
Chartmill
Despite its impressive fundamentals, NASDAQ:NBIX remains undervalued.
June 20, 2024
Via
Chartmill
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
Via
InvestorPlace
Is NASDAQ:NBIX on the Verge of a Major Breakout as a Strong Growth Stock?
June 14, 2024
Via
Chartmill
Key Takeaways From Neurocrine Biosciences Analyst Ratings
May 28, 2024
Via
Benzinga
Exploring NASDAQ:NBIX's quality characteristics.
May 27, 2024
Via
Chartmill
Exploring the Growth Potential of NASDAQ:NBIX as It Nears a Breakout.
May 24, 2024
Via
Chartmill
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Via
Investor's Business Daily
Don't overlook NASDAQ:NBIX—a stock with solid growth prospects and a reasonable valuation.
June 13, 2024
Via
Chartmill
In the world of growth stocks, NASDAQ:NBIX shines as a value proposition.
May 23, 2024
Via
Chartmill
Nvidia Leads Five Stocks Near Buy Points As Market Rally Picks Up Steam
May 04, 2024
Via
Investor's Business Daily
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
May 03, 2024
Via
Investor's Business Daily
Why Quality Investors May Find NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Attractive.
May 03, 2024
Via
Chartmill
NASDAQ:NBIX, a strong growth stock, setting up for a breakout.
May 02, 2024
Via
Chartmill
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
May 03, 2024
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Despite its growth, NASDAQ:NBIX remains within the realm of affordability.
May 02, 2024
Via
Chartmill
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.